Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy

Our previous study aimed to investigate overall survival (OS) and sudden cardiac death (SCD) variables in nonischemic dilated cardiomyopathy (DCM) patients treated only with standard medical treatments versus those who received implantable cardioverter defibrillator (ICD) in addition to routine medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehi Omran, Hossein, Irilouzadian, Rana, Hedayati Goudarzi, Mohammad Taghi, Salehi Omran, Mohammad Taghi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577569/
https://www.ncbi.nlm.nih.gov/pubmed/37605641
http://dx.doi.org/10.1002/clc.24138
Descripción
Sumario:Our previous study aimed to investigate overall survival (OS) and sudden cardiac death (SCD) variables in nonischemic dilated cardiomyopathy (DCM) patients treated only with standard medical treatments versus those who received implantable cardioverter defibrillator (ICD) in addition to routine medical treatments. Our findings revealed no significant difference in OS between the two groups (p = .25), but a significant decrease in SCD rate due to ICD insertion (p = .02). Furthermore, we found no significant difference between the two groups concerning baseline characteristics and type of medical treatments received. We attempted to answer and clarify the concerning points regarding the survival benefits of ICD insertion in nonischemic DCM patients that were mentioned. [Image: see text]

Ejemplares similares